Cohort validation pack
DASH
Determinants of Adolescent Social Wellbeing & Health
Generated 6 Oct 2026, 10:35 · ID 73
Last verified: 13/08/2026
Instructions for reviewers
- Review each field against your knowledge of this cohort. Mark Accurate if the value is right, Needs correction if it is wrong or inaccurate (add notes), Not sure if you cannot verify it, or Does not apply if the field is not relevant.
- Evidence shown is from our source registry. Fields marked No source yet hold values we could not yet pin to a document — those were AI-inferred and need your input most. Fields marked Searched — not published are ones we looked for and could not find publicly; the note lists where we checked.
- Your selections and notes are kept in this browser tab only (not sent to the database). Print or save as PDF when finished, then return it to the DIGIT team.
Overview
102
Total fields
85
Field-cited
0
Whole-record source only
0
AI-inferred, no source yet
12
Searched — not published
12
No value held
14
Needs review
Source coverage
Summary of how well fields in this pack are linked to evidence.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Field-level source coverage Optional | 85 of 97 reviewable fields are cited to a source (88%) · 0 with no source yet · 12 searched — not published · 12 with no value held | Computed | No citation linked to this field yet. | No response selected | No notes |
Identity and ownership
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Short name Required | DASH | Field-cited |
| No response selected | No notes |
Full name Required | Determinants of Adolescent Social Wellbeing & Health | Field-cited |
| No response selected | No notes |
Managing organisation Recommended | King's College London / MRC-CSO Social and Public Health Sciences Unit, University of Glasgow | Field-cited |
| No response selected | No notes |
Primary site Recommended | Institute of Psychiatry, Psychology & Neuroscience (site #13) | Field-cited |
| No response selected | No notes |
Website URL Recommended | https://www.kcl.ac.uk/research/dash-2 | Field-cited |
| No response selected | No notes |
Catalogue of Mental Health Measures URL Recommended | https://www.cataloguementalhealth.ac.uk/DASH | Field-cited |
| No response selected | No notes |
Contact name Recommended | Professor Seeromanie Harding | Field-cited |
| No response selected | No notes |
Contact email Recommended | seeromanie.harding@kcl.ac.uk | Field-cited |
| No response selected | No notes |
Summary and status
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Description Required | Multi-ethnic school-based cohort of 6,643 pupils recruited in 2002/2003 at ages 11-13 from 51 secondary schools across 10 inner London boroughs (Brent, Croydon, Hackney, Hammersmith & Fulham, Haringey, Lambeth, Newham, Southwark, Waltham Forest and Wandsworth), designed to examine how social conditions — family life, school life and neighbourhoods — shape ethnic differences in mental health, cardiovascular and respiratory health. Around 80% of participants are from ethnic minority groups, sampled to give substantial numbers of Black Caribbean, Black African, Indian and Pakistani/Bangladeshi young people. Follow-up ran in 2005/2006 at ages 14-16 (4,785 participants, 72% of the baseline cohort), a postal, telephone and online sweep in 2010/2011 at ages 19-21, and a 10% feasibility sub-sample of 665 at ages 21-23 completed in March 2014 which added blood biomarkers, accelerometry and qualitative interviews. Mental health is measured by the self-report Strengths and Difficulties Questionnaire across adolescence and the GHQ-12 in early adulthood. | Field-cited |
| No response selected | No notes |
Total N Required | 6,643 | Field-cited |
| No response selected | No notes |
Total N qualifier Recommended | baseline_participants | Field-cited |
| No response selected | No notes |
Year established Recommended | 2002 | Field-cited |
| No response selected | No notes |
Active cohort Recommended | Yes | Field-cited |
| No response selected | No notes |
Ongoing recruitment Recommended | No | Field-cited |
| No response selected | No notes |
Refreshed cohort Recommended | No | Field-cited |
| No response selected | No notes |
Recontact success rate Recommended | 97.00 | Field-cited |
| No response selected | No notes |
Retention rate Recommended | 72.00 | Field-cited |
| No response selected | No notes |
Published references Recommended | doi:10.1093/ije/dym094, doi:10.1007/s00127-015-1047-9, doi:10.1136/bmjopen-2016-013221, doi:10.1186/s12966-019-0780-y | Field-cited |
| No response selected | No notes |
Notes Recommended | Acronym expansion varies across the study's own outputs: the 2007 cohort profile and current KCL/catalogue records use "Determinants of Adolescent Social Wellbeing & Health", while the 2015 review title uses "Determinants of young Adult Social well-being and Health" to reflect the cohort ageing into adulthood. Published wave-2 participant counts also differ between the study's own papers (4,785 in the 2015 Methods and 2016 BMJ Open; 4,779 in the 2015 Appendix Table 3, the 2019 paper and the Catalogue of Mental Health Measures; 4,782 in the 2015 abstract); retention_rate uses the authors' own repeated "72% of the initial cohort" figure rather than selecting between numerators. primary_site_id=13 (IoPPN) is used as this database's King's College London anchor: DASH is a KCL study, but it sits in the Department of Population Health Sciences, School of Life Course & Population Health Sciences — not in the IoPPN. A dedicated KCL population-health site row would be more precise. The legacy project website dash.sphsu.mrc.ac.uk is retired and now serves only a notice pointing to the University of Glasgow Enlighten record (eprints.gla.ac.uk/353350), which is a metadata stub linking to a Conifer web capture on a platform discontinued in June 2026; the live KCL project page is therefore used as website_url. | Field-cited |
| No response selected | No notes |
3D cohort mapping
Consent, characterisation, and data availability axes used on the cohort map.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Consent level (axis) Required | 3 — Broad consent (recontactable for future studies) | Field-cited |
| No response selected | No notes |
Characterisation depth (axis) Required | 3 — Multi-domain MH characterisation | Field-cited |
| No response selected | No notes |
Data availability (axis) Required | 4 — Multi-modal | Field-cited |
| No response selected | No notes |
Cohort map group (derived) Recommended | Group 1 | Internal | Internal catalogue field | — | — |
Population type Recommended | General population | Field-cited |
| No response selected | No notes |
Industry engagement status Recommended | Unknown | Not published |
| No response selected | No notes |
Parent cohort / programme Recommended | No value held | Not published | No response selected | No notes | |
TWiCs eligible Recommended | No | Field-cited |
| No response selected | No notes |
Data modalities
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Questionnaire / interview Recommended | Yes | Field-cited |
| No response selected | No notes |
Cognitive testing Recommended | No | Field-cited |
| No response selected | No notes |
Physical measures Recommended | Yes | Field-cited |
| No response selected | No notes |
Biosamples Recommended | Yes | Field-cited |
| No response selected | No notes |
Genomic data Recommended | No | Field-cited |
| No response selected | No notes |
Omics Recommended | No | Field-cited |
| No response selected | No notes |
Imaging Recommended | No | Field-cited |
| No response selected | No notes |
Wearable / sensor Recommended | Yes | Field-cited |
| No response selected | No notes |
Digital phenotyping Recommended | No | Field-cited |
| No response selected | No notes |
Linked health records Recommended | No | Field-cited |
| No response selected | No notes |
Biosample types Recommended | saliva, blood, DNA | Field-cited |
| No response selected | No notes |
Genotyping platform Recommended | No value held | Field-cited |
| No response selected | No notes |
Imaging modalities Recommended | No value held | Field-cited |
| No response selected | No notes |
Mental health measures Recommended | Strengths and Difficulties Questionnaire (SDQ), 25-item self-report, General Health Questionnaire (GHQ-12), Parental Bonding Instrument (PBI) | Field-cited |
| No response selected | No notes |
Data subcategories
Structured modality and subcategory rows used alongside the high-level data-type flags.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Data modality: Blood sample Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · biosamples · biospecimen type · parent: Biospecimen collection · 25 ml blood sample at 21-23y for biochemistry, haematology and gut hormones, with storage · Feasibility sub-sample only (N=665); the source notes relatively high missing data for blood biomarkers. | Field-cited |
| No response selected | No notes |
Data modality: DNA sample Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · biosamples · biospecimen type · parent: Biospecimen collection · DNA extracted and stored from the 21-23y blood sample · DNA was extracted and stored but no genotyping or sequencing is reported. | Field-cited |
| No response selected | No notes |
Data modality: Saliva sample Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · biosamples · biospecimen type · parent: Biospecimen collection · Saliva collected at 11-13y for cotinine assay · Used to validate self-reported smoking in a sub-sample. | Field-cited |
| No response selected | No notes |
Data modality: Biospecimen collection Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · biosamples · category marker · Saliva at 11-13y; 25 ml blood at 21-23y | Field-cited |
| No response selected | No notes |
Data modality: Genotyping array Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | not available · genomics · derived genomic data · The Catalogue of Mental Health Measures records genetic data as not collected. DNA was extracted and stored from the 21-23y blood draw, but no genotyping or sequencing has been reported. | Field-cited |
| No response selected | No notes |
Data modality: Linked NHS records Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | not available · linked health records · category marker · No NHS/HES record linkage is asserted by any source. 85-90% of the 2012-2014 feasibility sub-sample consented to linkage of health and administrative records, but consent to future linkage is not evidence that linkage was established. Administrative linkage actually held is school-level education data. | Field-cited |
| No response selected | No notes |
Data modality: Clinical / physical measurements Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · physical measures · category marker · Physical measures taken by trained field assistants/nurses at all three sweeps · Also includes lung function (FEV, FVC, PF) and arterial stiffness (pulse wave velocity and augmentation index by TensioWin Arteriograph 24), which have no dedicated vocabulary keys. | Field-cited |
| No response selected | No notes |
Data modality: Anthropometry Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · physical measures · clinical physical measure · parent: Clinical / physical measurements · Standing height, sitting height, weight, waist, hip and arm circumference at all three sweeps; pubertal stage at 11-13y and 14-16y | Field-cited |
| No response selected | No notes |
Data modality: Blood pressure / vitals Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · physical measures · clinical physical measure · parent: Clinical / physical measurements · Blood pressure at all three sweeps | Field-cited |
| No response selected | No notes |
Data modality: Body composition Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · physical measures · clinical physical measure · parent: Clinical / physical measurements · Bio-impedance at 14-16y and 21-23y | Field-cited |
| No response selected | No notes |
Data modality: Lipid profile Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · physical measures · clinical physical measure · parent: Clinical / physical measurements · Total and HDL cholesterol, plus HbA1c, from the 21-23y blood sample · Blood biomarkers were collected only at 21-23y, in the feasibility sub-sample. | Field-cited |
| No response selected | No notes |
Data modality: Questionnaire / interview data Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · questionnaires · category marker · Main self-complete questionnaire at all three sweeps: socio-economic circumstances, family life, psychosocial measures, lifestyle, health, parental health | Field-cited |
| No response selected | No notes |
Data modality: GHQ-12 / GHQ Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · questionnaires · questionnaire instrument · parent: Questionnaire / interview data · GHQ-12 at 21-23y; score of 4 or more indicates psychological distress · Collected only in the 665-participant feasibility sub-sample. | Field-cited |
| No response selected | No notes |
Data modality: Parental Bonding Instrument (PBI) Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · questionnaires · questionnaire instrument · parent: Questionnaire / interview data · Brief form of the Parental Bonding Instrument; perceived parental care and control · Psychosocial exposure measure rather than a mental health outcome. | Field-cited |
| No response selected | No notes |
Data modality: SDQ Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · questionnaires · questionnaire instrument · parent: Questionnaire / interview data · 25-item self-report SDQ at 11-13y and 14-16y; Total Difficulties Score summed from 20 items · Used as a screening instrument. A cut-off of TDS>17 identifies probable clinical cases; no diagnostic interview was administered. | Field-cited |
| No response selected | No notes |
Data modality: Accelerometry Recommended Confirm this row is correctly typed as a category marker, named instrument/interview, biospecimen type, assay/data product, imaging modality, sensor stream, or linked-record type; add missing named instruments/sample types where known. | available · wearables · wearable sensor data · activPAL accelerometry at 21-23y · Feasibility sub-sample only (N=665), not the whole cohort. | Field-cited |
| No response selected | No notes |
Consent and use permissions
Specific use permissions separate from the 3D consent-level axis.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Consent/use: Biosample research use Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | permitted · biosample use · local operational permission · 2012-2014 feasibility sub-sample (N=665) · Blood was collected explicitly for storage and DNA extraction; consent rates ranged between 85 and 90% for the new biomedical measures. Per the information sheet, stored blood/DNA is held by the MRC as custodian (not owner) for use in future research into the genetic basis for disease and response to treatment, with a documented participant withdrawal route. | Field-cited |
| No response selected | No notes |
Consent/use: Industry / commercial research considered Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | unknown · commercial use · local operational permission · No public statement on industry or commercial access. Mirrors industry_engagement_status=unknown; to be established directly with the cohort owners. | Not published |
| No response selected | No notes |
Consent/use: Health record linkage permitted Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | permitted · data linkage · local operational permission · 2012-2014 feasibility sub-sample (N=665) · Consent rates of 85-90% were achieved for linkage of health and administrative records; the information sheet names the targets as information held by the NHS Information Centre and records maintained by the General Register Office. Consent was obtained; the linkage itself is not reported as established. | Field-cited |
| No response selected | No notes |
Consent/use: Data sharing permitted Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | permitted · data sharing · local operational permission · All consented participants · Data sharing policy follows MRC guidance with the stated aim of making data as widely and freely available as possible while safeguarding participant privacy. | Field-cited |
| No response selected | No notes |
Consent/use: Collaboration required Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | restricted · governance · duo modifier · All applicants · All potential collaborators work with a link person, an experienced DASH researcher, to support access to and analysis of the data. | Field-cited |
| No response selected | No notes |
Consent/use: Section 251 / CAG support Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | not applicable · governance · legal governance context · DASH operates on individual informed consent, not Section 251/CAG support. | Field-cited |
| No response selected | No notes |
Consent/use: Participant recontact permitted Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | permitted · recontact · local operational permission · Explicit for 2012-14 feasibility participants; wider cohort via the study-held contact register · The feasibility information sheet explicitly asked permission to contact participants again about findings and possible further studies, stating that any future study would come with its own consent. The team maintained a contact register with an update-your-contact-details route on the study website and mailed the cohort for the 2010 postal sweep; 81% of the cohort (5,414 of 6,643) was traceable in 2012-14. Whole-cohort standing recontact-consent wording is not published — confirm scope with the owners. | Field-cited |
| No response selected | No notes |
Consent/use: Health / medical / biomedical research use Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | permitted · research use · duo permission · DUO:0000002 · All consented participants · Ethical approval from the Multi-centre Research Ethics Committee and, while participants were at school, local education authorities; informed consent obtained from all participants. | Field-cited |
| No response selected | No notes |
Consent/use: Approach for trials permitted Recommended Confirm status, population scope, whether the permission is a DUO-style restriction/permission or a local operational permission, and whether academic and industry/commercial use differ. | unknown · trial approach · local operational permission · No source states that participants consented to be approached about clinical trials. DASH is registered as an observational study with no intervention. To be confirmed with the cohort owners. | Field-cited |
| No response selected | No notes |
Access pathways
One or more routes by which researchers can request or analyse data.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Access pathway: Collaboration required Recommended Confirm route, access level, environment type, DAC review, collaboration, data sharing agreement, output checking, platform, timeline, cost, URL, and whether multiple routes are possible. | available on application · access level: custodian review · environment: unknown · collaboration required · DASH study team link person · Free · All potential collaborators work with a link person, an experienced DASH researcher, to support their access to and analysis of the data. Variable-level metadata is described as available from the study team. | Field-cited |
| No response selected | No notes |
Access pathway: Direct application Recommended Confirm route, access level, environment type, DAC review, collaboration, data sharing agreement, output checking, platform, timeline, cost, URL, and whether multiple routes are possible. | available on application · access level: custodian review · environment: unknown · collaboration required · MRC-CSO Social and Public Health Sciences Unit, University of Glasgow · Free · Researchers submit a data request to the MRC Social and Public Health Sciences Unit. The Catalogue of Mental Health Measures describes the route as a project proposal. Environment type is unknown: no source states whether data are released as an extract or analysed in a controlled environment. Cost reflects the HDR UK Gateway record, which sets usage rights to Free while marking access as Restricted; no fee schedule is published. | Field-cited |
| No response selected | No notes |
Within-cohort coverage
Aggregate counts or percentages showing how broadly data, consent, or access characteristics apply within the cohort.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Coverage: Cohort successfully traced for the 2012-2014 follow-up Recommended Confirm numerator, denominator, unit type, exactness qualifiers, denominator type, basis, as-of date/release, source wording, and whether the metric is marginal, joint, conditional, or a release total. | 5,414 / 6,643 (81.5%) · unit: participants · denominator: total cohort · basis: unknown · status: available · release: 2012-2014 feasibility sub-sample (21-23y) · scope: marginal · source value: 81% (5414 of 6643) of the cohort was traced through friendship networks, social media, and community campaigns · Tracing (locating) success, roughly a decade after baseline — the practical ceiling on any future recontact. coverage_basis is 'unknown' because the controlled vocabulary has no value for tracing/locating; the exact source wording is preserved in source_value. | Field-cited |
| No response selected | No notes |
Coverage: Completed a qualitative interview at 21-23y Recommended Confirm numerator, denominator, unit type, exactness qualifiers, denominator type, basis, as-of date/release, source wording, and whether the metric is marginal, joint, conditional, or a release total. | 42 / 665 (6.32%) · unit: participants · denominator: wave respondents · basis: completed · status: available · release: 2012-2014 feasibility sub-sample (21-23y) · scope: marginal · source value: 42 qualitative interviews · Identified using stratified purposeful sampling across gender, ethnicity, religion, family type and socio-economic circumstances. Qualitative interview data has no data_modalities vocabulary key, so no target entity is set. | Field-cited |
| No response selected | No notes |
Coverage: Participated in the 14-16y follow-up sweep Recommended Confirm numerator, denominator, unit type, exactness qualifiers, denominator type, basis, as-of date/release, source wording, and whether the metric is marginal, joint, conditional, or a release total. | 4,785 / 6,643 (72.03%) · unit: participants · denominator: total cohort · basis: completed · status: available · release: 2005/2006 sweep (14-16y) · scope: marginal · source value: 4785 (88% of children in 49 schools, 72% of the initial cohort) · The study's own papers publish three different numerators for this sweep: 4,785 (2015 Methods and 2016 BMJ Open), 4,779 (2015 Appendix Table 3, 2019 paper, Catalogue of Mental Health Measures) and 4,782 (2015 abstract, 2018 paper). 4,785 is used here as the figure given in the Methods sections; the authors' own summary percentage of 72% is what cohorts.retention_rate records. | Field-cited |
| No response selected | No notes |
Coverage: Participated in the 21-23y feasibility follow-up Recommended Confirm numerator, denominator, unit type, exactness qualifiers, denominator type, basis, as-of date/release, source wording, and whether the metric is marginal, joint, conditional, or a release total. | 665 / 6,643 (10.01%) · unit: participants · denominator: total cohort · basis: completed · status: available · release: 2012-2014 feasibility sub-sample (21-23y) · scope: marginal · source value: A 10% subsample (N=665, 97% participation rate) · A deliberate 10% sub-sample of roughly 100 per major ethnic group, representative by gender and socio-economic circumstances — not a whole-cohort sweep. The 97% figure is participation among those invited, not among the full cohort. All blood biomarker, accelerometry and GHQ-12 data are confined to this sub-sample. | Field-cited |
| No response selected | No notes |
Linkage and access
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
NHS linkage Recommended | No | Field-cited |
| No response selected | No notes |
GP linkage Recommended | No | Field-cited |
| No response selected | No notes |
Death registry linkage Recommended | No | Field-cited |
| No response selected | No notes |
Education linkage Recommended | Yes | Field-cited |
| No response selected | No notes |
Data access mechanism Recommended | direct_application | Field-cited |
| No response selected | No notes |
TRE platform Recommended | No value held | Not published |
| No response selected | No notes |
Data dictionary URL Recommended | No value held | Not published |
| No response selected | No notes |
Data access timeline (days) Recommended | No value held | Not published |
| No response selected | No notes |
Data access cost Recommended | Free | Field-cited |
| No response selected | No notes |
Participant profile and dates
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Age distribution Recommended | Cohort year of birth: ~1990; Approximate age in 2026: 34-37 (mid-30s); Aged 11-13 at recruitment (2002/03): 1 | Field-cited |
| No response selected | No notes |
Sex distribution Recommended | No value held | Not published |
| No response selected | No notes |
Ethnicity distribution Recommended | Basis: Six-group split of the 4,785 participants followed from ages 11-13 to 14-16; Indian: 0.088; White UK: 0.182; Black African: 0.186; Black Caribbean: 0.163; Other (mainly mixed): 0.288; Pakistani/Bangladeshi: 0.093; Ethnic minority (baseline): 0.8 | Field-cited |
| No response selected | No notes |
Smoking status distribution Recommended | Measure: Ever smoked, self-report; M/F = males/females (cotinine-validated sub-sample at ages 11-13); Indian, 11-13: M 9.6% · F 6.9%; Indian, 14-16: M 24.9% · F 27.5%; White UK, 11-13: M 25.6% · F 26.4%; White UK, 14-16: M 51.1% · F 65.3%; Black African, 11-13: M 19.5% · F 13.8%; Black African, 14-16: M 27.1% · F 31.9%; Black Caribbean, 11-13: M 22.8% · F 28.9%; Black Caribbean, 14-16: M 36.5% · F 55.3%; Other (mainly mixed), 11-13: M 22.7% · F 24.6%; Other (mainly mixed), 14-16: M 43.3% · F 51.1%; Pakistani/Bangladeshi, 11-13: M 20.2% · F 12.2%; Pakistani/Bangladeshi, 14-16: M 39.0% · F 33.8%; Whole-sample ever-smoked figure: Not published | Field-cited |
| No response selected | No notes |
Median age Recommended | No value held | Not published |
| No response selected | No notes |
Percent female Recommended | No value held | Not published |
| No response selected | No notes |
Percent non-white Recommended | 80.00 | Field-cited |
| No response selected | No notes |
Geographic coverage Recommended | regional | Field-cited |
| No response selected | No notes |
Follow-up duration Recommended | Baseline 2002/2003 (ages 11-13); follow-up 2005/2006 (ages 14-16); postal/telephone/online sweep 2010/2011 (ages 19-21); feasibility sub-sample 2012-2014 (ages 21-23) | Field-cited |
| No response selected | No notes |
Last data collection date Recommended | No value held | Not published |
| No response selected | No notes |
Recruitment start date Recommended | No value held | Not published |
| No response selected | No notes |
Recruitment end date Recommended | No value held | Not published |
| No response selected | No notes |
Diagnosis areas
Mental health diagnosis areas represented in this cohort.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Diagnosis area: Major depressive disorder Recommended Confirm this diagnosis area applies and estimated N if shown. | Major depressive disorder · Mood Disorders | Field-cited |
| No response selected | No notes |
Diagnosis area: Generalised anxiety disorder Recommended Confirm this diagnosis area applies and estimated N if shown. | Generalised anxiety disorder · Anxiety Disorders | Field-cited |
| No response selected | No notes |
Diagnosis area: Transdiagnostic (anxiety-depression) Recommended Confirm this diagnosis area applies and estimated N if shown. | Transdiagnostic (anxiety-depression) · Transdiagnostic | Field-cited |
| No response selected | No notes |
Linked sites
Sites contributing participants or data to this cohort.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Linked site: Institute of Psychiatry, Psychology & Neuroscience Recommended | Institute of Psychiatry, Psychology & Neuroscience · London | Field-cited |
| No response selected | No notes |
Linked site: University of Glasgow / NHS Greater Glasgow and Clyde Recommended | University of Glasgow / NHS Greater Glasgow and Clyde · Scotland | Field-cited |
| No response selected | No notes |
Verification metadata
Internal catalogue status — for reference only.
| Field | Current value | Evidence | Source evidence | Response | Notes / correction |
|---|---|---|---|---|---|
Verification status Recommended | unverified | Internal | Internal catalogue field | — | — |
Last verified Recommended | 13 Aug 2026 | Internal | Internal catalogue field | — | — |
Data source Recommended | Verified Aug 2026 against the KCL DASH project page and KCL staff profile for Prof Seeromanie Harding, ClinicalTrials.gov NCT03283332 (API v2), Europe PMC full text for Harding et al. 2015 Soc Psychiatry Psychiatr Epidemiol (PMC4519637), Harding et al. 2016 BMJ Open (PMC5223645) and Huang et al. 2019 Int J Behav Nutr Phys Act (PMC6368762), the Catalogue of Mental Health Measures DASH record, the HDR UK Gateway dataset record mirrored at find.data.gov.scot/datasets/26270 (published by DATAMIND), the retired dash.sphsu.mrc.ac.uk notice, and an ISRCTN XML API search returning no DASH registration. The 2007 IJE cohort profile (doi:10.1093/ije/dym094) is not open access, so it is cited for title and DOI only. Consent model re-investigated Aug 2026 against the archived DASH feasibility Participant Information Sheet v6 (03/10/12) and the 2010 study-website FAQ, both retrieved via the Wayback Machine. | Internal | Internal catalogue field | — | — |